Skip to content

Dr. Pieter Daelemans

Active
Private limited companyfounded 2020active for 6 yearsBenoit Ballonstraat 26, 1785 Merchtem, BelgiumKBO/BCE: BE 0746.476.366
Summary

Dr. Pieter Daelemans has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €120,784 and a net result of €116,050. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 30% of 20,461 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€327,149total assets 2025
Equity
€120,784
Profit
€116,050
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 36 days early0 of 1 deed read
Why 93lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.61, cash €130,462Size: total assets €327,149Figures for financial year 2025 (filed 25-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 43% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 62-38
equity 36.9% of total assets
Liquidity 68-32
short-term debt 60.8% · cash 39.9%
Profitability 100=
return on assets 35.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,011 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.61, compared with 89.37 in 2024; short-term debt: 60.8% and cash: 39.9% of total assets), but 63.1% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 31% on solvency, 48% on liquidity, 80% on profitability and 12% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk○neutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.61, cash €130,462
NBB · annual accounts
lowers risk · Size: total assets €327,149
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 25-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
36 days early
2024
16 days early
2023
1 day early
2022
14 days early
2021
7 days late
2020
54 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 1 day before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2020 to 2025net €116,050 ▲43.1%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Caution: Equity fell in 2025from €238,381 to €120,784 ▼ 49.3% View
  • Positive: 6 profitable years in a rowprofit 2025: €116,050 6 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Total assets
€327,149
Profit
€116,050
Solvency
36.9%
Total assets▲ 28.3%
Net result
20202025
Go to Financials

Timeline

Events
11
Since
2021
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 30-07-2024Annual accounts filed
  3. 31-12-2023Liquidity more than quadruples
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
23-04-2020
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.